← Leaderboards
Absalon Dennis Gutierrez
University Of Texas Hlth Sci Ctr Houston
$4,044,189
Attributed
$4,044,189
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $906.5K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,044,189 · 2
By mechanism
R01$3,461,897 · 1
R21$582,292 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Christopher D Verrico$5,355,734
- Luba Yammine$1,357,533
- Brian R. Davis$2,799,415
- Jocelyne H Bachevalier$13,246,208
- Holly Ann Hill$121,930
Others in their field
Other Emerging Leaders on “Metabolic”
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Rainer Lohmann · University Of Rhode Island$14,400,221
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
MetabolicGlucagon-Like Peptide 1MeasurementResponseNon-Insulin-Dependent Diabetes MellitusGlucosePlasmaLinkObesityPrediabetes SyndromePhysiologicalChronicClinical TrialsDiabetes MellitusAgonistGlp-I ReceptorBaseAftercareChronic DiseaseCohortComorbidityCardiovascular SystemBody Weight DecreasedBlood Glucose
Grant awards (8)
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes$701,211
R01 · FY2025 · DK · contact PI
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes$665,637
R01 · FY2024 · DK · contact PI
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes$694,913
R01 · FY2023 · DK · contact PI
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes$688,675
R01 · FY2022 · DK · contact PI
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans with Prediabetes$711,461
R01 · FY2021 · DK · contact PI
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response$195,000
R21 · FY2021 · DK · contact PI
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response$194,792
R21 · FY2020 · DK · contact PI
GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response$192,500
R21 · FY2019 · DK · contact PI